Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

doi:10.1084/jem.178.5.1541

This Article

	Full Text (PDF, 10691K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Ando, K.
	Articles by Chisari, F. V.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Ando, K.
	Articles by Chisari, F. V.


Social Bookmarking

	What's this?

ARTICLES

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

K Ando, T Moriyama, LG Guidotti, S Wirth, RD Schreiber, HJ Schlicht, SN Huang and FV Chisari
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037.

The molecular and cellular mechanisms responsible for cytotoxic T lymphocyte (CTL)-induced immunopathology are not well defined. Using a model in which hepatitis B surface antigen (HBsAg)-specific CTL cause an acute necroinflammatory liver disease in HBsAg transgenic mice, we demonstrate that class I-restricted disease pathogenesis is an orderly, multistep process that involves direct as well as indirect consequences of CTL activation. It begins (step 1) almost immediately as a direct antigen-specific CTL-target cell interaction that triggers the HBsAg- positive hepatocyte to undergo programmed cell death (apoptosis). It progresses (step 2) within hours to a focal inflammatory response in which antigen-nonspecific lymphocytes and neutrophils amplify the local cytopathic effect of the CTL. The most destructive pathogenetic function of the CTL, however, is to secrete interferon gamma when they encounter antigen in vivo, thereby activating the intrahepatic macrophage and inducing a delayed-type hypersensitivity response (step 3) that destroys the liver and kills the mouse. We propose that the principles illustrated in this study are generally applicable to other models of class I-restricted, CTL-induced immunopathology, and we suggest that they contribute to the immunopathogenesis of viral hepatitis during hepatitis B virus infection in humans.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Ito, H., Ando, K., Ishikawa, T., Saito, K., Takemura, M., Imawari, M., Moriwaki, H., Seishima, M. (2009). Role of TNF-{alpha} Produced by Nonantigen-Specific Cells in a Fulminant Hepatitis Mouse Model. J. Immunol. 182: 391-397 [Abstract] [Full Text]
Das, A., Hoare, M., Davies, N., Lopes, A. R., Dunn, C., Kennedy, P. T.F., Alexander, G., Finney, H., Lawson, A., Plunkett, F. J., Bertoletti, A., Akbar, A. N., Maini, M. K. (2008). Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. JEM 205: 2111-2124 [Abstract] [Full Text]
Ito, H., Ando, K., Ishikawa, T., Nakayama, T., Taniguchi, M., Saito, K., Imawari, M., Moriwaki, H., Yokochi, T., Kakumu, S., Seishima, M. (2008). Role of V{alpha}14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of V{alpha}14+ NKT cells promotes the breakage of CTL tolerance. Int Immunol 20: 869-879 [Abstract] [Full Text]
Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., Das, A., Lopes, A. R., Borrow, P., Williams, K., Humphreys, E., Afford, S., Adams, D. H., Bertoletti, A., Maini, M. K. (2007). Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. JEM 204: 667-680 [Abstract] [Full Text]
Maier, H., Isogawa, M., Freeman, G. J., Chisari, F. V. (2007). PD-1:PD-L1 Interactions Contribute to the Functional Suppression of Virus-Specific CD8+ T Lymphocytes in the Liver. J. Immunol. 178: 2714-2720 [Abstract] [Full Text]
Sitia, G., Iannacone, M., Muller, S., Bianchi, M. E., Guidotti, L. G. (2007). Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J. Leukoc. Biol. 81: 100-107 [Abstract] [Full Text]
Tsuchiyama, T., Nakamoto, Y., Sakai, Y., Marukawa, Y., Kitahara, M., Mukaida, N., Kaneko, S. (2007). Prolonged, NK Cell-Mediated Antitumor Effects of Suicide Gene Therapy Combined with Monocyte Chemoattractant Protein-1 against Hepatocellular Carcinoma. J. Immunol. 178: 574-583 [Abstract] [Full Text]
Kurachi, M., Kakimi, K., Ueha, S., Matsushima, K. (2007). Maintenance of memory CD8+ T cell diversity and proliferative potential by a primary response upon re-challenge. Int Immunol 19: 105-115 [Abstract] [Full Text]
Budhu, A., Wang, X. W. (2006). The role of cytokines in hepatocellular carcinoma. J. Leukoc. Biol. 80: 1197-1213 [Abstract] [Full Text]
Wuensch, S. A., Pierce, R. H., Crispe, I. N. (2006). Local Intrahepatic CD8+ T Cell Activation by a Non-Self- Antigen Results in Full Functional Differentiation. J. Immunol. 177: 1689-1697 [Abstract] [Full Text]
Liu, M., Mendicino, M., Ning, Q., Ghanekar, A., He, W., McGilvray, I., Shalev, I., Pivato, D., Clark, D. A., Phillips, M. J., Levy, G. A. (2006). Cytokine-Induced Hepatic Apoptosis Is Dependent on FGL2/Fibroleukin: The Role of Sp1/Sp3 and STAT1/PU.1 Composite cis Elements.. J. Immunol. 176: 7028-7038 [Abstract] [Full Text]
Kimura, K., Nagaki, M., Nishihira, J., Satake, S., Kuwata, K., Moriwaki, H. (2006). Role of macrophage migration inhibitory factor in hepatitis B virus-specific cytotoxic-T-lymphocyte-induced liver injury.. CVI 13: 415-419 [Abstract] [Full Text]
Takai, S., Kimura, K., Nagaki, M., Satake, S., Kakimi, K., Moriwaki, H. (2005). Blockade of Neutrophil Elastase Attenuates Severe Liver Injury in Hepatitis B Transgenic Mice. J. Virol. 79: 15142-15150 [Abstract] [Full Text]
Biburger, M., Tiegs, G. (2005). {alpha}-Galactosylceramide-Induced Liver Injury in Mice Is Mediated by TNF-{alpha} but Independent of Kupffer Cells. J. Immunol. 175: 1540-1550 [Abstract] [Full Text]
Chen, A., Wang, L., Zhang, J., Zou, L., Jia, Z., Zhou, W., Wan, Y., Wu, Y. (2005). H-2 Kd-Restricted Hepatitis B Virus-Derived Epitope Whose Specific CD8+ T Lymphocytes Can Produce Gamma Interferon without Cytotoxicity. J. Virol. 79: 5568-5576 [Abstract] [Full Text]
Wendling, D, Auge, B, Bettinger, D, Lohse, A, Le Huede, G, Bresson-Hadni, S, Toussirot, E, Miguet, J-P, Herbein, G, Di Martino, V (2005). Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy. Ann Rheum Dis 64: 788-789 [Full Text]
Wang, W.-H., Gregori, G., Hullinger, R. L., Andrisani, O. M. (2004). Sustained Activation of p38 Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase Pathways by Hepatitis B Virus X Protein Mediates Apoptosis via Induction of Fas/FasL and Tumor Necrosis Factor (TNF) Receptor 1/TNF-{alpha} Expression. Mol. Cell. Biol. 24: 10352-10365 [Abstract] [Full Text]
Cao, Q., Xia, Y., Azadniv, M., Crispe, I. N. (2004). The E2F-1 Transcription Factor Promotes Caspase-8 and Bid Expression, and Enhances Fas Signaling in T Cells. J. Immunol. 173: 1111-1117 [Abstract] [Full Text]
Yajima, T., Nishimura, H., Saito, K., Kuwano, H., Yoshikai, Y. (2004). Overexpression of Interleukin-15 Increases Susceptibility to Lipopolysaccharide-Induced Liver Injury in Mice Primed with Mycobacterium bovis Bacillus Calmette-Guerin. Infect. Immun. 72: 3855-3862 [Abstract] [Full Text]
Nakamoto, Y., Suda, T., Momoi, T., Kaneko, S. (2004). Different Procarcinogenic Potentials of Lymphocyte Subsets in a Transgenic Mouse Model of Chronic Hepatitis B. Cancer Res. 64: 3326-3333 [Abstract] [Full Text]
Kasahara, S., Ando, K., Saito, K., Sekikawa, K., Ito, H., Ishikawa, T., Ohnishi, H., Seishima, M., Kakumu, S., Moriwaki, H. (2003). Lack of Tumor Necrosis Factor Alpha Induces Impaired Proliferation of Hepatitis B Virus-Specific Cytotoxic T Lymphocytes. J. Virol. 77: 2469-2476 [Abstract] [Full Text]
Schumann, J., Muhlen, K., Kiemer, A. K., Vollmar, A. M., Tiegs, G. (2003). Parenchymal, But Not Leukocyte, TNF Receptor 2 Mediates T Cell-Dependent Hepatitis in Mice. J. Immunol. 170: 2129-2137 [Abstract] [Full Text]
Babas, T., Munoz, D., Mankowski, J. L., Tarwater, P. M., Clements, J. E., Zink, M. C. (2002). Role of Microglial Cells in Selective Replication of Simian Immunodeficiency Virus Genotypes in the Brain. J. Virol. 77: 208-216 [Abstract] [Full Text]
Kimura, K., Kakimi, K., Wieland, S., Guidotti, L. G., Chisari, F. V. (2002). Activated Intrahepatic Antigen-Presenting Cells Inhibit Hepatitis B Virus Replication in the Liver of Transgenic Mice. J. Immunol. 169: 5188-5195 [Abstract] [Full Text]
Nakamoto, Y., Kaneko, S., Fan, H., Momoi, T., Tsutsui, H., Nakanishi, K., Kobayashi, K., Suda, T. (2002). Prevention of Hepatocellular Carcinoma Development Associated with Chronic Hepatitis by Anti-Fas Ligand Antibody Therapy. JEM 196: 1105-1111 [Abstract] [Full Text]
Sitia, G., Isogawa, M., Kakimi, K., Wieland, S. F., Chisari, F. V., Guidotti, L. G. (2002). Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 99: 13717-13722 [Abstract] [Full Text]
Kakimi, K., Isogawa, M., Chung, J., Sette, A., Chisari, F. V. (2002). Immunogenicity and Tolerogenicity of Hepatitis B Virus Structural and Nonstructural Proteins: Implications for Immunotherapy of Persistent Viral Infections. J. Virol. 76: 8609-8620 [Abstract] [Full Text]
Nakamoto, Y., Kaneko, S., Kobayashi, K. (2002). Increased susceptibility to apoptosis and attenuated Bcl-2 expression in T lymphocytes and monocytes from patients with advanced chronic hepatitis C. J. Leukoc. Biol. 72: 49-55 [Abstract] [Full Text]
Trobonjaca, Z., Kroger, A., Stober, D., Leithauser, F., Moller, P., Hauser, H., Schirmbeck, R., Reimann, J. (2002). Activating Immunity in the Liver. II. IFN-{beta} Attenuates NK Cell-Dependent Liver Injury Triggered by Liver NKT Cell Activation. J. Immunol. 168: 3763-3770 [Abstract] [Full Text]
Kakimi, K., Lane, T. E., Wieland, S., Asensio, V. C., Campbell, I. L., Chisari, F. V., Guidotti, L. G. (2001). Blocking Chemokine Responsive to {gamma}-2/Interferon (IFN)-{gamma} Inducible Protein and Monokine Induced by IFN-{gamma} Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus-specific Cytotoxic T Lymphocytes. JEM 194: 1755-1766 [Abstract] [Full Text]
Balkow, S., Kersten, A., Tran, T. T. T., Stehle, T., Grosse, P., Museteanu, C., Utermohlen, O., Pircher, H., von Weizsacker, F., Wallich, R., Mullbacher, A., Simon, M. M. (2001). Concerted Action of the FasL/Fas and Perforin/Granzyme A and B Pathways Is Mandatory for the Development of Early Viral Hepatitis but Not for Recovery from Viral Infection. J. Virol. 75: 8781-8791 [Abstract] [Full Text]
Trobonjaca, Z., Leithauser, F., Moller, P., Schirmbeck, R., Reimann, J. (2001). Activating Immunity in the Liver. I. Liver Dendritic Cells (but Not Hepatocytes) Are Potent Activators of IFN-{gamma} Release by Liver NKT Cells. J. Immunol. 167: 1413-1422 [Abstract] [Full Text]
Navas, S., Seo, S.-H., Chua, M. M., Sarma, J. D., Lavi, E., Hingley, S. T., Weiss, S. R. (2001). Murine Coronavirus Spike Protein Determines the Ability of the Virus To Replicate in the Liver and Cause Hepatitis. J. Virol. 75: 2452-2457 [Abstract] [Full Text]
Sette, A. D., Oseroff, C., Sidney, J., Alexander, J., Chesnut, R. W., Kakimi, K., Guidotti, L. G., Chisari, F. V. (2001). Overcoming T Cell Tolerance to the Hepatitis B Virus Surface Antigen in Hepatitis B Virus-Transgenic Mice. J. Immunol. 166: 1389-1397 [Abstract] [Full Text]
Bajt, M. L., Lawson, J. A., Vonderfecht, S. L., Gujral, J. S., Jaeschke, H. (2000). Protection against Fas Receptor-Mediated Apoptosis in Hepatocytes and Nonparenchymal Cells by a Caspase-8 Inhibitor in Vivo: Evidence for a Postmitochondrial Processing of Caspase-8. Toxicol Sci 58: 109-117 [Abstract] [Full Text]
Schumann, J., Wolf, D., Pahl, A., Brune, K., Papadopoulos, T., van Rooijen, N., Tiegs, G. (2000). Importance of Kupffer Cells for T-Cell-Dependent Liver Injury in Mice. Am. J. Pathol. 157: 1671-1683 [Abstract] [Full Text]
Pasquetto, V., Wieland, S., Chisari, F. V. (2000). Intracellular Hepatitis B Virus Nucleocapsids Survive Cytotoxic T-Lymphocyte-Induced Apoptosis. J. Virol. 74: 9792-9796 [Abstract] [Full Text]
Voehringer, D., Blaser, C., Grawitz, A. B., Chisari, F. V., Buerki, K., Pircher, H. (2000). Break of T Cell Ignorance to a Viral Antigen in the Liver Induces Hepatitis. J. Immunol. 165: 2415-2422 [Abstract] [Full Text]
Ohta, A., Sekimoto, M., Sato, M., Koda, T., Nishimura, S.-i., Iwakura, Y., Sekikawa, K., Nishimura, T. (2000). Indispensable Role for TNF-{alpha} and IFN-{gamma} at the Effector Phase of Liver Injury Mediated by Th1 Cells Specific to Hepatitis B Virus Surface Antigen. J. Immunol. 165: 956-961 [Abstract] [Full Text]
Schirmbeck, R., Wild, J., Stober, D., Blum, H. E., Chisari, F. V., Geissler, M., Reimann, J. (2000). Ongoing Murine T1 or T2 Immune Responses to the Hepatitis B Surface Antigen Are Excluded from the Liver that Expresses Transgene-Encoded Hepatitis B Surface Antigen. J. Immunol. 164: 4235-4243 [Abstract] [Full Text]
Rehermann, B. (2000). Intrahepatic T Cells in Hepatitis B: Viral Control versus Liver Cell Injury. JEM 191: 1263-1268 [Abstract] [Full Text]
Maini, M. K., Boni, C., Lee, C. K., Larrubia, J. R., Reignat, S., Ogg, G. S., King, A. S., Herberg, J., Gilson, R., Alisa, A., Williams, R., Vergani, D., Naoumov, N. V., Ferrari, C., Bertoletti, A. (2000). The Role of Virus-specific CD8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection. JEM 191: 1269-1280 [Abstract] [Full Text]
Guidotti, L. G., McClary, H., Loudis, J. M., Chisari, F. V. (2000). Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice. JEM 191: 1247-1252 [Abstract] [Full Text]
Ichikawa, K., Yoshida-Kato, H., Ohtsuki, M., Ohsumi, J., Yamaguchi, J., Takahashi, S., Tani, Y., Watanabe, M., Shiraishi, A., Nishioka, K., Yonehara, S., Serizawa, N. (2000). A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity. Int Immunol 12: 555-562 [Abstract] [Full Text]
Chisari, F. V. (2000). Viruses, Immunity, and Cancer: Lessons from Hepatitis B. Am. J. Pathol. 156: 1117-1132 [Full Text]
McClary, H., Koch, R., Chisari, F. V., Guidotti, L. G. (2000). Relative Sensitivity of Hepatitis B Virus and Other Hepatotropic Viruses to the Antiviral Effects of Cytokines. J. Virol. 74: 2255-2264 [Abstract] [Full Text]
Schweyer, S, Mihm, S, Radzun, H J, Hartmann, H, Fayyazi, A (2000). Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection. Gut 46: 255-259 [Abstract] [Full Text]
Shankar, P., Xu, Z., Lieberman, J. (1999). Viral-Specific Cytotoxic T Lymphocytes Lyse Human Immunodeficiency Virus-Infected Primary T Lymphocytes by the Granule Exocytosis Pathway. Blood 94: 3084-3093 [Abstract] [Full Text]
Kimura, K., Ando, K., Ohnishi, H., Ishikawa, T., Kakumu, S., Takemura, M., Muto, Y., Moriwaki, H. (1999). Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A. Int Immunol 11: 1491-1500 [Abstract] [Full Text]
Heise, T., Guidotti, L. G., Chisari, F. V. (1999). La Autoantigen Specifically Recognizes a Predicted Stem-Loop in Hepatitis B Virus RNA. J. Virol. 73: 5767-5776 [Abstract] [Full Text]
Nishimura, T., Ohta, A. (1999). A Critical Role for Antigen-Specific Th1 Cells in Acute Liver Injury in Mice. J. Immunol. 162: 6503-6509 [Abstract] [Full Text]
Guidotti, L. G., Borrow, P., Brown, A., McClary, H., Koch, R., Chisari, F. V. (1999). Noncytopathic Clearance of Lymphocytic Choriomeningitis Virus from the Hepatocyte. JEM 189: 1555-1564 [Abstract] [Full Text]
Matsushita, T., Ando, K., Kimura, K., Ohnishi, H., Imawari, M., Muto, Y., Moriwaki, H. (1999). IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo. Int Immunol 11: 657-665 [Abstract] [Full Text]
Ishikawa, T., Kono, D., Chung, J., Fowler, P., Theofilopoulos, A., Kakumu, S., Chisari, F. V. (1998). Polyclonality and Multispecificity of the CTL Response to a Single Viral Epitope. J. Immunol. 161: 5842-5850 [Abstract] [Full Text]
Shimizu, Y., Guidotti, L. G., Fowler, P., Chisari, F. V. (1998). Dendritic Cell Immunization Breaks Cytotoxic T Lymphocyte Tolerance in Hepatitis B Virus Transgenic Mice. J. Immunol. 161: 4520-4529 [Abstract] [Full Text]
Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P., Chisari, F. V. (1998). Immune Pathogenesis of Hepatocellular Carcinoma. JEM 188: 341-350 [Abstract] [Full Text]
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., Nagata, S. (1997). Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing. JEM 186: 2045-2050 [Abstract] [Full Text]
Liu, C.-C., Young, L. H.Y., Young, J. D.-E (1996). Lymphocyte-Mediated Cytolysis and Disease. NEJM 335: 1651-1659 [Full Text]
Nagata, S, Golstein, P (1995). The Fas death factor. Science 267: 1449-1456 [Abstract]
Nietsch, H. H., Roe, M. W., Fiekers, J. F., Moore, A. L., Lidofsky, S. D. (2000). Activation of Potassium and Chloride Channels by Tumor Necrosis Factor alpha . ROLE IN LIVER CELL DEATH. J. Biol. Chem. 275: 20556-20561 [Abstract] [Full Text]